Lv1
68 积分 2022-11-22 加入
The OX40 / OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis
3个月前
已完结
CS2015, A TSLP/OX40L BISPECIFIC ANTIBODY, AS A POTENTIAL NOVEL THERAPEUTIC AGENT FOR TYPE2 INFLAMMATION DISEASES
3个月前
已完结
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial
4个月前
已完结
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial
4个月前
已完结
Penetration pathways, influencing factors and predictive models for dermal absorption of exobiotic molecules: A critical review
5个月前
已完结
Dermal Drug Development Strategies
6个月前
已完结
Penetration pathways, influencing factors and predictive models for dermal absorption of exobiotic molecules: A critical review
6个月前
已完结
Assessing Topical Efficacy
6个月前
已完结
Topical Drug Candidate Selection Criteria and Cascade
6个月前
已完结
Nemolizumab for the treatment of atopic dermatitis
6个月前
已完结
皖公网安备34019202002308
